Angene Chemical
Draw
|
Currency :
Home Products

AG0072OT

198904-31-3 | Atazanavir

Chemical structure of Atazanavir, CAS 198904-31-3
AG0072OT
sdsSDS
sdsCOA

Price

$0.00

Add to Cart
WARNING This product is not for human or veterinary use.
Request For Quotation
CAS Number 198904-31-3
Catalog Number AG0072OT(AGN-PC-0QQ85Q)
Chemical Name Atazanavir
EC Number 812-543-8
IUPAC Name methyl N-[(2S)-1-[2-[(2S,3S)-2-hydroxy-3-[[(2S)-2-(methoxycarbonylamino)-3,3-dimethylbutanoyl]amino]-4-phenylbutyl]-2-[(4-pyridin-2-ylphenyl)methyl]hydrazinyl]-3,3-dimethyl-1-oxobutan-2-yl]carbamate
InChI InChI=1S/C38H52N6O7/c1-37(2,3)31(41-35(48)50-7)33(46)40-29(22-25-14-10-9-11-15-25)30(45)24-44(43-34(47)32(38(4,5)6)42-36(49)51-8)23-26-17-19-27(20-18-26)28-16-12-13-21-39-28/h9-21,29-32,45H,22-24H2,1-8H3,(H,40,46)(H,41,48)(H,42,49)(H,43,47)/t29-,30-,31+,32+/m0/s1
InChI Key AXRYRYVKAWYZBR-GASGPIRDSA-N
MDL Number MFCD08435966
Molecular Formula C38H52N6O7
Molecular Weight 704.8555
SMILES O=C(N[C@H](C(NN(C[C@@H]([C@@H](NC([C@@H](NC(OC)=O)C(C)(C)C)=O)CC1=CC=CC=C1)O)CC2=CC=C(C=C2)C3=NC=CC=C3)=O)C(C)(C)C)OC
UNII QZU4H47A3S
Synonyms
232632, BMS, 3,12-bis(1,1-dimethylethyl)-8-hydroxy-4,11-dioxo-9-(phenylmethyl)-6-((4-(2-pyridinyl)phenyl)methyl)-2,5,6,10,13-pentaazatetradecanedioic acid dimethyl ester, atazanavir, atazanavir sulfate, BMS 232632, BMS 232632 05, BMS-232632, BMS-232632-05, BMS232632, BMS23263205, CGP 73547, CGP 75136, CGP 75176, CGP 75355, CGP-73547, CGP-75136, CGP-75176, CGP-75355, CGP73547, CGP75136, CGP75176, CGP75355, Reyataz, Atazanavir, 198904-31-3, Latazanavir, Reyataz, Zrivada, BMS-232632, BMS 232632, Atazanavir [INN:BAN], CGP 73547, Atazanavir Base, UNII-QZU4H47A3S, CGP-73547, HSDB 7339, Reyataz (TN), ATV, CHEMBL1163, QZU4H47A3S, CHEBI:37924, (3S,8S,9S,12S)-3,12-BIS(1,1-DIMETHYLETHYL)-8-HYDROXY-4,11-DIOXO-9-(PHENYLMETHYL)-6-[[4-(2-PYRIDINYL)PHENYL]METHYL]-2,5,6,10,13-PENTAAZATETRADECANEDIOIC ACID DIMETHYL ESTER, NCGC00182552-01, DSSTox_CID_28617, DSSTox_RID_82887, DSSTox_GSID_48691, DR7, atazanavirum, 2,5,6,10,13-Pentaazatetradecanedioic acid, 3,12-bis(1,1-dimethylethyl)-8-hydroxy-4,11-dioxo-9-(phenylmethyl)-6-((4-(2-pyridinyl)phenyl)methyl)-, dimethyl ester, (3S,8S,9S,12S)-, 2,5,6,10,13-Pentaazatetradecanedioic acid, 3,12-bis(1,1-dimethylethyl)-8-hydroxy-4,11-dioxo-9-(phenylmethyl)-6-((4-(2-pyridinyl)phenyl)methyl)-, dimethyl ester, (3S-(3R*,8R*,9R*,12R*))-, Atazanavir (INN), methyl N-[(1S)-1-[[(1S,2S)-1-benzyl-2-hydroxy-3-[[[(2S)-2-(methoxycarbonylamino)-3,3-dimethyl-butanoyl]amino]-[[4-(2-pyridyl)phenyl]methyl]amino]propyl]carbamoyl]-2,2-dimethyl-propyl]carbamate, methyl N-[(1S)-1-{N'-[(2S,3S)-2-hydroxy-3-[(2S)-2-[(methoxycarbonyl)amino]-3,3-dimethylbutanamido]-4-phenylbutyl]-N'-{[4-(pyridin-2-yl)phenyl]methyl}hydrazinecarbonyl}-2,2-dimethylpropyl]carbamate, CAS-198904-31-3, atazanavir-reyataz, 2aqu, Reyataz(TM) (*1:1 sulfate*), AK174307, methyl N-[(2S)-1-[2-[(2S,3S)-2-hydroxy-3-[[(2S)-2-(methoxycarbonylamino)-3,3-dimethylbutanoyl]amino]-4-phenylbutyl]-2-[(4-pyridin-2-ylphenyl)methyl]hydrazinyl]-3,3-dimethyl-1-oxobutan-2-yl]carbamate, PubChem22425, AC1L3WMH, ATV & AAG, ATV & HSA, Reyataz;BMS-232632, SCHEMBL41696, Atazanavir, >=98% (HPLC), DTXSID9048691, Atazanavir & human serum albumin, BDBM13934, CTK8E8692, KS-00000XJF, AOB5590, AXRYRYVKAWYZBR-GASGPIRDSA-N, HMS2089P22, ACT06755, Atazanavir(BMS-232632)/Reyataz, ZINC3941496, Tox21_113081, ABP000606, CA0144, MFCD08435966, Atazanavir & alpha1-acid glycoprotein, AKOS025396423, Tox21_113081_1, AN-6727, CS-0945, DB01072, SB19156, NCGC00182552-02, NCGC00182552-03, (2S)-N-(3-{[(2S)-2-(Methoxycarbonylamino)-3,3-dimethylbutanoylamino][(4-(2-pyridyl)phenyl)methyl]amino}(1S,2S)-2-hydroxy-1-benzylpropyl)-2-(methoxycarbonylamino)-3,3-dimethylbutanamide, dimethyl (3S,8S,9S,12S)-9-benzyl-3,12-di-tert-butyl-8-hydroxy-4,11-dioxo-6-[4-(2-pyridyl)benzyl]-2,5,6,10,13-pentaazatetradecanedioate, HY-17367, METHYL [(1S,4S,5S,10S)-4-BENZYL-1,10-DI-TERT-BUTYL-5-HYDROXY-2,9,12-TRIOXO-7-(4-PYRIDIN-2-YLBENZYL)-13-OXA-3,7,8,11-TETRAAZATETRADEC-1-YL]CARBAMATE, AB0073035, AB2000541, LS-183909, LS-187373, RT-011330, TL8001639, FT-0662313, S4662, A25022, D07471, S-7876, AB01274792-01, AB01274792-02, AB01274792-03, AB01274792_04, 114589-EP2272830A1, 114589-EP2298783A1, SR-01000930924, J-519602, SR-01000930924-2, 3,12-Bis(1,1-dimethylethyl)-8-hydroxy-4,11-dioxo-9-(phenylmethyl)-6-[[4-(2-pyridinyl)phenyl]methyl]-, 1,14-dimethyl ester, (3s,8s,9s,12s)-2,5,6,10,13-pentaazatetradecanedioic acid, ATAZANAVIR; METHYL [(1S,4S,5S,10S)-4-BENZYL-1,10-DI-TERT-BUTYL-5-HYDROXY-2,9,12-TRIOXO-7-(4-PYRIDIN-2-YLBENZYL)-13-OXA-3,7,8,11-TETRAAZATETRADEC-1-YL]CARBAMATE, Atazanavir;(2S)-N-(3-{[(2S)-2-(Methoxycarbonylamino)-3,3-dimethylbutanoylamino][(4-(2-pyridyl)phenyl)methyl]amino}(1S,2S)-2-hydroxy-1-benzylpropyl)-2-(methoxycarbonylamino)-3,3-dimethylbutanamide, methyl ((5S,10S,11S,14S)-11-benzyl-5-(tert-butyl)-10-hydroxy-15,15-dimethyl-3,6,13-trioxo-8-(4-(pyridin-2-yl)benzyl)-2-oxa-4,7,8,12-tetraazahexadecan-14-yl)carbamate, methyl ((5S,8S,9S,14S)-8-benzyl-5-(tert-butyl)-9-hydroxy-15,15-dimethyl-3,6,13-trioxo-11-(4-(pyridin-2-yl)benzyl)-2-oxa-4,7,11,12-tetraazahexadecan-14-yl)carbamate, methyl [(1S,4S,5S,10S)-4-benzyl-1,10-di-tert-butyl-5-hydroxy-2,9,12-trioxo-7-(4-pyridin-2-ylbenzyl)-13-oxa-3,7,8,11-tetraazatetradec-1-yl]carbamate (non-preferred name), methyl N-[(1S)-1-[[(2S,3S)-3-hydroxy-4-[[[(2S)-2-(methoxycarbonylamino)-3,3-dimethyl-butanoyl]amino]-[(4-pyridin-2-ylphenyl)methyl]amino]-1-phenyl-butan-2-yl]carbamoyl]-2,2-dimethyl-propyl]carbamate, methyl N-[(1S)-1-{[(2S,3S)-3-hydroxy-4-[(2S)-2-[(methoxycarbonyl)amino]-3,3-dimethyl-N''-{[4-(pyridin-2-yl)phenyl]methyl}butanehydrazido]-1-phenylbutan-2-yl]carbamoyl}-2,2-dimethylpropyl]carbamate, methyl N-[(2S)-1-[[(2S,3S)-3-hydroxy-4-[[[(2S)-2-(methoxycarbonylamino)-3,3-dimethylbutanoyl]amino]-[(4-pyridin-2-ylphenyl)methyl]amino]-1-phenylbutan-2-yl]amino]-3,3-dimethyl-1-oxobutan-2-yl]carbamate, Atazanavir sulfate, zidovudine, Atazanavir sulphate, D00AGO, D07IQS, cc-607, C38H52N6O7, CGP73547, CGP75136, CGP75176, CGP75355, BMS232632, CGP 75136, CGP 75176, CGP 75355, CGP-75136, CGP-75176, CGP-75355, CID148192, Reyataz, BMS-232632, Atazanavir, C38-H52-N6-O7, ACN-048229, 232632, BMS, BMS23263205, BMS 232632 05, BMS-232632-05, ATZ, A10097, C413408, D000069446, 162537-11-3, 229975-97-7, 3,12-bis(1,1-dimethylethyl)-8-hydroxy-4,11-dioxo-9-(phenylmethyl)-6-((4-(2-pyridinyl)phenyl)methyl)-2,5,6,10,13-pentaazatetradecanedioic acid dimethyl ester,

Related Research Chemicals

    CERTIFICATE OF ANALYSIS
    Chemical Name: Batch Number:
    Chemical Structure: CAS Registry No:
    		Product ID:
    Manufacture Date:
    Storage Temperature:
    Formula:
    Molecular Weight:
    Quantity:
    Analysis Data:
    Test: Result:
    Conclusion: The above product meets the specifications of Angene.
    Analyst:Chase
    Date:
    Reviewed by:Jessie
    Date:
    Angene International Limited